ScholarIQanswers from OpenAlex & ORCID
Cem Gabay
ResearcherPublications, citations & collaboration network
Cem Gabay is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Cem Gabay have?
ScholarIQindexed works
Cem Gabay has 495 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Cem Gabay have?
ScholarIQcitation count
Cem Gabay has 37,890 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Cem Gabay?
ScholarIQh-index
Cem Gabay has an h-index of 79 in OpenAlex.
What is the i10-index of Cem Gabay?
ScholarIQi10-index
Cem Gabay has an i10-index of 234 in OpenAlex.
What is the ORCID of Cem Gabay?
ScholarIQorcid
The ORCID for Cem Gabay is on the source record.
What is the OpenAlex record for Cem Gabay?
ScholarIQopenalex
The OpenAlex for Cem Gabay is on the source record.
What are the most-cited papers on Cem Gabay?
ScholarIQmost cited works
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde
\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.
Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, Maxime Dougados, Paul Emery, C. Gaujoux-Viala, Simone Gorter, Rachel Knevel, J. Nam, Monika Schoels, Daniel Aletaha, Maya H Buch, Laure Gossec, T. Huizinga, J. W. J. Bijlsma, Gerd R Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan J. Gómez‐Reino, Marios Kouloumas, Tore K Kvien, E. Martín‐Mola, Iain B. McInnes, Karel Pavelká, Piet L. C. M. van Riel, M. Scholte, David L. Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin Winthrop, John B. Wong, A. Zink, Désirée van der Heijde